Long-term drug survival of dupilumab and associated predictors in moderate-to-severe atopic dermatitis: A real-world prospective cohort study

Affiliations

¹ Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.
² Study Centre of the Italian Group for the Epidemiologic Research in Dermatology (GISED), Bergamo, Italy.
³ Dermatology Department, University of Brescia, Brescia, Italy.
⁴ Dermatology Department, University of Padua, Padua, Italy.
⁵ Dermatology Unit, Istituto Nazionale di Riposo e Cura per Anziani, INRCA-IRCCS Hospital, Ancona, Italy.

Elena Pezzolo et al. J Eur Acad Dermatol Venereol. 2023 Jun.

. 2023 Jun;37(6):e757-e759.

doi: 10.1111/jdv.18889. Epub 2023 Feb 6.

¹ Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.
² Study Centre of the Italian Group for the Epidemiologic Research in Dermatology (GISED), Bergamo, Italy.
³ Dermatology Department, University of Brescia, Brescia, Italy.
⁴ Dermatology Department, University of Padua, Padua, Italy.
⁵ Dermatology Unit, Istituto Nazionale di Riposo e Cura per Anziani, INRCA-IRCCS Hospital, Ancona, Italy.

No abstract available

References

1. Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers. 2018;21:1.
1. Wollenberg A, Christen-Zäch S, Taieb A, Paul C, Thyssen JP, de Bruin-Weller M, et al. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adult and children. J Eur Acad Dermatol Venereol. 2020;34:2717-44.
1. Beck LA, Thaçi D, Hamilton JD, Graham NM, Bieber T, Rocklin R, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014;371:130-9.
1. Napolitano M, Fabbrocini G, Neri I, Stingeni L, Boccaletti V, Piccolo V, et al. Dupilumab treatment in children aged 6-11 years with atopic dermatitis: a multicentre, real-life study. Paediatr Drugs. 2022;24(6):671-8.
1. Dal Bello G, Maurelli M, Schena D, Girolomoni G, Gisondi P. Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients. Dermatol Ther. 2020;33(6):e13979.